Why the study?
Only few patients with heart failure with preserved ejection fraction undergo durable mechanical circulatory support implantation.
Durable mechanical circulatory support is feasible as a bridge-to-transplant therapy in select patients with HFpEF when using tailored surgical techniques.
Answers are grounded in this paper and cite their sources.
Supports technical feasibility of LVAD in select HFpEF patients; leaves open questions on safety and generalizability.
Only few patients with heart failure with preserved ejection fraction undergo durable mechanical circulatory support implantation. We identified three patients with heart failure with preserved ejection fraction who needed durable mechanical circulatory support as bridge-to-transplant therapy. In two patients with hypertrophic cardiomyopathy, the hypertrophic papillary muscles and myocardium were resected to allow for subsequent left ventricular assist device implantation. In one patient, all visible parts of the mitral valve were additionally resected. The third patient with restrictive cardiomyopathy underwent Berlin Heart Excor BVAD implantation with left atrial cannulation.
No takes yet. Share an insight, caveat, or question.
Lanmüeller et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: